Advertisement OrthoScan raises $7.5 million in financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

OrthoScan raises $7.5 million in financing

OrthoScan, a privately held medical device company, has closed a $7.5 million series B financing led by River Cities Capital Funds.

Additional participants include existing investors Aphelion Capital, California Technology Ventures and a group of accredited private individuals.

Carter McNabb, managing director of River Cities Capital Funds has joined OrthoScan’s board in connection with the financing.

Rob Morocco, COO of OrthoScan, said: “This round of financing will provide us with the resources necessary to further expand our sales distribution in the US and abroad. Additionally, we will continue to improve the design and performance of our Mini-C Arm product as well as develop fluoroscopic imaging products which will allow us to expand our customer base.”